Snowball logo
logo
RARE_logo

Ultragenyx Pharmaceutical Inc

RARE β€’ NASDAQ
$16.08+$0.43Β  (2.75%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
351.4363.3434.2560.2673716.9
COGS
16.0128.3245.2176.73109121
Gross Profit
335.4335389483.5564595.9
Operating Expenses & Income
Operating Income
(381.7)(648.9)(569.2)(536)(535)(528.9)
Total Operating Expenses
717.1983.9958.21,019.51,0991,124.8
R&D Expenses
497.2705.8648.4697.9750773.2
Selling General & Admin Expenses
220278.1309.8321.6349350.6
Earnings from Continuing Operations
Interest Expense
(29.42)(43.02)(66)(63.04)(62)(76.15)
Interest Income
1.92811.0726.6936.512523.38
Income Tax Expense
1.0445.696(1.825)1.59743.873
Net Income
Net Income
(454)(707.4)(606.6)(569.2)(575)(586.4)
Supplemental
EBIT
(423.6)(658.7)(542.5)(504.5)(509)(506.4)
EBITDA
(410.3)(640.5)(516.5)(469)(474)(473)
In millions of USD, except % and values per 1 share